Clinical predictors of relapse after treatment of primary gastrointestinal cytomegalovirus disease in solid organ transplant recipients

American Journal of Transplantation

Volumn 10, Issue 1, 2010, Pages 157-161

  Eid, A J ^a   Arthurs, S K ^a   Deziel, P J ^a   Wilhelm, M P ^a   Razonable, R R ^a  

^a MAYO CLINIC   (United States)

Author keywords

CMV disease; Gastroenteritis; Rejection; Viral decline; Viral load

Indexed keywords

GANCICLOVIR; VALGANCICLOVIR;

ADULT; ANTIVIRAL THERAPY; ARTICLE; CLINICAL ARTICLE; CLINICAL PRACTICE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DRUG DOSE REDUCTION; FEMALE; FOLLOW UP; GASTROINTESTINAL BIOPSY; GASTROINTESTINAL INFECTION; GRAFT RECIPIENT; HEART TRANSPLANTATION; HISTOPATHOLOGY; HUMAN; INFECTION PREVENTION; INFECTION RISK; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MAINTENANCE THERAPY; MALE; MEDICAL RECORD REVIEW; ORGAN TRANSPLANTATION; POLYMERASE CHAIN REACTION; PREDICTOR VARIABLE; PRIORITY JOURNAL; RELAPSE; RETROSPECTIVE STUDY; SEROCONVERSION; TREATMENT DURATION; VIREMIA; VIRUS LOAD;

ADULT; ANTIVIRAL AGENTS; COHORT STUDIES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; GANCICLOVIR; GASTROINTESTINAL DISEASES; HEART TRANSPLANTATION; HUMANS; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROGNOSIS; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; TRANSPLANTS; VIRAL LOAD; VIREMIA;

EID: 72549111679     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2009.02861.x     Document Type: Article

References (15)

1. Eid AJ, Razonable RR. Cytomegalovirus disease in solid organ transplant recipients: Advances lead to new challenges and opportunities. Curr Opin Organ Transplant 2007 12 : 610 617.
2. Paya C, Humar A, Dominguez E et al. Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients. Am J Transplant 2004 4 : 611 620.
3. Arthurs SK, Eid AJ, Pedersen RA et al. Delayed-onset primary cytomegalovirus disease after liver transplantation. Liver Transpl 2007 13 : 1703 1709.
4. Arthurs SK, Eid AJ, Pedersen RA et al. Delayed-onset primary cytomegalovirus disease and the risk of allograft failure and mortality after kidney transplantation. Clin Infect Dis 2008 46 : 840 846.
5. Kijpittayarit-Arthurs S, Eid AJ, Kremers WK et al. Clinical features and outcomes of delayed-onset primary cytomegalovirus disease in cardiac transplant recipients. J Heart Lung Transplant 2007 26 : 1019 1024.
6. Cytomegalovirus. Am J Transplant 2004 4 (Suppl 10 51 58.
7. Asberg A, Humar A, Rollag H et al. Oral valganciclovir is noninferior to intravenous ganciclovir for the treatment of cytomegalovirus disease in solid organ transplant recipients. Am J Transplant 2007 7 : 2106 2113.
8. Preiksaitis JK, Brennan DC, Fishman J, Allen U. Canadian society of transplantation consensus workshop on cytomegalovirus management in solid organ transplantation final report. Am J Transplant 2005 5 : 218 227.
9. Sia IG, Wilson JA, Groettum CM, Espy MJ, Smith TF, Paya CV. Cytomegalovirus (CMV) DNA load predicts relapsing CMV infection after solid organ transplantation. J Infect Dis 2000 181 : 717 720.
10. Ljungman P, Griffiths P, Paya C. Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis 2002 34 : 1094 1097.
11. Humar A, Kumar D, Boivin G, Caliendo AM. Cytomegalovirus (CMV) virus load kinetics to predict recurrent disease in solid-organ transplant patients with CMV disease. J Infect Dis 2002 186 : 829 833.
12. Humar A, Gregson D, Caliendo AM et al. Clinical utility of quantitative cytomegalovirus viral load determination for predicting cytomegalovirus disease in liver transplant recipients. Transplantation 1999 68 : 1305 1311.
13. Humar A, Mazzulli T, Moussa G et al. Clinical utility of cytomegalovirus (CMV) serology testing in high-risk CMV D+/R- transplant recipients. Am J Transplant 2005 5 : 1065 1070.
14. Cummins NW, Deziel PJ, Abraham RS, Razonable RR. Deficiency of cytomegalovirus (CMV)-specific CD8+ T cells in patients presenting with late-onset CMV disease several years after transplantation. Transpl Infect Dis 2009 11 : 20 27.
15. Mattes FM, Vargas A, Kopycinski J et al. Functional impairment of cytomegalovirus specific CD8 T cells predicts high-level replication after renal transplantation. Am J Transplant 2008 8 : 990 999.